Literature DB >> 29523691

Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity.

Mitsunori Shiroishi1, Yuji Ito2, Kenta Shimokawa2, Jae Man Lee3, Takahiro Kusakabe3, Tadashi Ueda4.   

Abstract

Rheumatoid factors (RFs) are autoantibodies against the fragment-crystallizable (Fc) region of IgG. In individuals with hematological diseases such as cryoglobulinemia and certain B cell lymphoma forms, the RFs derived from specific heavy- and light-chain germline pairs, so-called "stereotypic RFs," are frequently produced in copious amounts and form immune complexes with IgG in serum. Of note, many structural details of the antigen recognition mechanisms in RFs are unclear. Here we report the crystal structure of the RF YES8c derived from the IGHV1-69/IGKV3-20 germline pair, the most common of the stereotypic RFs, in complex with human IgG1-Fc at 2.8 Å resolution. We observed that YES8c binds to the CH2-CH3 elbow in the canonical antigen-binding manner involving a large antigen-antibody interface. On the basis of this observation, combined with mutational analyses, we propose a recognition mechanism common to IGHV1-69/IGKV3-20 RFs: (1) the interaction of the Leu432-His435 region of Fc enables the highly variable complementarity-determining region (CDR)-H3 to participate in the binding, (2) the hydrophobic tip in the CDR-H2 typical of IGHV1-69 antibodies recognizes the hydrophobic patch on Fc, and (3) the interaction of the highly conserved RF light chain with Fc is important for RF activity. These features may determine the putative epitope common to the IGHV1-69/IGKV3-20 RFs. We also showed that some mutations in the binding site of RF increase the affinity to Fc, which may aggravate hematological diseases. Our findings unravel the structural basis for germline-encoded antibody autoreactivity.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  IgG; autoimmunity; complex; crystal structure; structural biology

Mesh:

Substances:

Year:  2018        PMID: 29523691      PMCID: PMC5936827          DOI: 10.1074/jbc.M117.814475

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen.

Authors:  C H Chan; K G Hadlock; S K Foung; S Levy
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

2.  Evidence that human immunoglobulin M rheumatoid factors can Be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts.

Authors:  M O Carayannopoulos; K N Potter; Y Li; J B Natvig; J D Capra
Journal:  Scand J Immunol       Date:  2000-04       Impact factor: 3.487

3.  Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction.

Authors:  A L Corper; M K Sohi; V R Bonagura; M Steinitz; R Jefferis; A Feinstein; D Beale; M J Taussig; B J Sutton
Journal:  Nat Struct Biol       Date:  1997-05

4.  The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes.

Authors:  V Pascual; I Randen; K Thompson; M Sioud; O Forre; J Natvig; J D Capra
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

5.  Restricted diversity of the variable region nucleotide sequences of the heavy and light chains of a human rheumatoid factor.

Authors:  I Ezaki; H Kanda; K Sakai; N Fukui; M Shingu; M Nobunaga; T Watanabe
Journal:  Arthritis Rheum       Date:  1991-03

6.  Nucleotide sequence analysis of rheumatoid factors and polyreactive antibodies derived from patients with rheumatoid arthritis reveals diverse use of VH and VL gene segments and extensive variability in CDR-3.

Authors:  V Pascual; K Victor; I Randen; K Thompson; M Steinitz; O Førre; S M Fu; J B Natvig; J D Capra
Journal:  Scand J Immunol       Date:  1992-08       Impact factor: 3.487

7.  Towards automated crystallographic structure refinement with phenix.refine.

Authors:  Pavel V Afonine; Ralf W Grosse-Kunstleve; Nathaniel Echols; Jeffrey J Headd; Nigel W Moriarty; Marat Mustyakimov; Thomas C Terwilliger; Alexandre Urzhumtsev; Peter H Zwart; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-03-16

8.  Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.

Authors:  Richard J Bende; Wilhelmina M Aarts; Robert G Riedl; Daphne de Jong; Steven T Pals; Carel J M van Noesel
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

9.  Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.

Authors:  Tianlei Ying; Ponraj Prabakaran; Lanying Du; Wei Shi; Yang Feng; Yanping Wang; Lingshu Wang; Wei Li; Shibo Jiang; Dimiter S Dimitrov; Tongqing Zhou
Journal:  Nat Commun       Date:  2015-09-15       Impact factor: 14.919

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  6 in total

1.  Immunoglobulin G structure and rheumatoid factor epitopes.

Authors:  Sheila Lefoli Maibom-Thomsen; Nicole Hartwig Trier; Bettina Eide Holm; Kirsten Beth Hansen; Morten Ib Rasmussen; Anna Chailyan; Paolo Marcatili; Peter Højrup; Gunnar Houen
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

Review 2.  Structural Basis of a Conventional Recognition Mode of IGHV1-69 Rheumatoid Factors.

Authors:  Mitsunori Shiroishi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Relationships of Rheumatoid Factor with Thickness of Retina and Choroid in Subjects without Ocular Symptoms Using Swept-Source Optical Coherence Tomography.

Authors:  Qingjian Li; Yiwen Qian; Sennan Xu; Minjie Zhang; Xu Liang; Xin Che; Jing Jiang; Zuguo Liu; Yu Zhang; Yan Liu; Zhiliang Wang
Journal:  J Immunol Res       Date:  2021-03-24       Impact factor: 4.818

Review 4.  Autoantibody:Autoantigen Competitor Decoys: Application to Cardiac Phenotypes.

Authors:  Timothy Cardozo; Lila Cardozo; Mohamed Boutjdir
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

Review 5.  COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.

Authors:  Christopher C Goodnow
Journal:  Immunol Cell Biol       Date:  2020-11-23       Impact factor: 5.126

6.  Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System.

Authors:  Takeru Ebihara; Akitsu Masuda; Daisuke Takahashi; Masato Hino; Hiroaki Mon; Kohei Kakino; Tsuguru Fujii; Ryosuke Fujita; Tadashi Ueda; Jae Man Lee; Takahiro Kusakabe
Journal:  Mol Biotechnol       Date:  2021-07-25       Impact factor: 2.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.